Abstract:Avermectin (AVM), a compound derived from the fermentation of Avermectin Streptomyces, has insecticidal, acaricidal, and nematicidal properties. Widely employed in agriculture, it serves as an effective and broad-spectrum insecticide for pest control. Although the toxicity of AVM at low doses may not be readily apparent, prolonged and extensive exposure can result in poisoning. To investigate the toxic effects of AVM on the body, this study established rat models of AVM poisoning with both low and high concentrations of the compound. Fifteen male rats were randomly assigned to one of three groups (n=5 per group): a control group, a low-concentration group, and a high-concentration group. The low-concentration group was administered an oral dose of 2 mg/kg AVM once daily for a duration of seven days, while the high-concentration group received an oral dose of 10 mg/kg AVM once daily for the same period. This study examined the impact of AVM on liver function and gut microbiota in rats using weight monitoring, liver function indicator detection, liver metabolomics sequencing, colon barrier function testing, and gut microbiota sequencing. The findings of this study demonstrated that exposure to 2 or 10 mg/kg AVM for seven days can lead to a notable decrease in rat weight, as well as induce liver dysfunction and metabolic disturbances. Additionally, AVM exposure can disrupt the composition of the intestinal microbiota and impair the integrity of the colon mucosal barrier, causing downregulation of Occludin expression and upregulation of inflammation-related protein expression levels such as IL-1β, Myd88, and TLR4. Furthermore, bioinformatics analysis revealed a significant association between liver dysfunction and dysbiosis of the gut microbiota. These findings have implications for the agricultural use of AVM and its potential contribution to environmental pollution. Consequently, individuals involved in AVM usage should prioritize safety precautions and monitor liver function.

Avermectin Confers Its Cytotoxic Effects by Inducing DNA Damage and Mitochondria-Associated Apoptosis

Cytotoxic Effects of Avermectin on Human HepG2 Cells in Vitro Bioassays.

Avermectin induced DNA damage to the apoptosis and autophagy in human lung epithelial A549 cells

Avermectin induces toxic effects in insect nontarget cells involves DNA damage and its associated programmed cell death

Ivermectin Confers Its Cytotoxic Effects by Inducing AMPK/mTOR-mediated Autophagy and DNA Damage.

Toxic effects of avermectin on liver function, gut microbiota, and colon barrier in the rat model

Loperamide, an Antidiarrheal Agent, Induces Apoptosis and DNA Damage in Leukemia Cells.

' s response to reviews Title : Voltage-dependent anion channel is involved in the apoptosis of cell lines carrying mitochondrial DNA A 4263 G mutation

Aurantiamide acetate suppresses the growth of malignant gliomas in vitro and in vivo by inhibiting autophagic flux.

Ivermectin Induces Cell Cycle Arrest and Apoptosis of HeLa Cells Via Mitochondrial Pathway.

Avermectin Induced Liver Injury in Pigeon: Mechanisms of Apoptosis and Oxidative Stress

Global DNA hypomethylation: A potential mechanism in King pigeon nerve tissue damage induced by avermectin

Effects of Avermectins on Neurite Outgrowth in Differentiating Mouse Neuroblastoma N2a Cells

Effects of Avermectin on Microsomal Cytochrome P450 Enzymes in the Liver and Kidneys of Pigeons.

Inhibition of TMEM16A Ca2+-activated Cl- channels by avermectins is essential for their anticancer effects

Antioxidant Response and Histopathological Changes in Brain Tissue of Pigeon Exposed to Avermectin.

Abamectin Induces Cytotoxicity Via the ROS, JNK, and ATM/ATR Pathways

Cytotoxicity and Autophagy Induced by Ivermectin via AMPK/mTOR Signaling Pathway in RAW264.7 Cells

Athyrium Multidentatum (doll.) Ching Extract Induce Apoptosis Via Mitochondrial Dysfunction and Oxidative Stress in HepG2 Cells.

Co-exposure of Avermectin and Imidacloprid Induces DNA Damage, Pyroptosis, and Immune Dysfunction in Epithelioma Papulosum Cyprini Cells Via ROS-mediated Keap1/Nrf2/TXNIP Axis.

Avermectin exerts anti-inflammatory effect by downregulating the nuclear transcription factor kappa-B and mitogen-activated protein kinase activation pathway.